[HTML][HTML] Clinical measures of bulbar dysfunction in ALS

Y Yunusova, EK Plowman, JR Green, C Barnett… - Frontiers in …, 2019 - frontiersin.org
Bulbar impairment represents a hallmark feature of Amyotrophic Lateral Sclerosis (ALS) that
significantly impacts survival and quality of life. Speech and swallowing dysfunction are key …

[HTML][HTML] Current clinical applications of diffusion-tensor imaging in neurological disorders

WS Tae, BJ Ham, SB Pyun… - Journal of Clinical …, 2018 - synapse.koreamed.org
Diffusion-tensor imaging (DTI) is a noninvasive medical imaging tool used to investigate the
structure of white matter. The signal contrast in DTI is generated by differences in the …

Multicenter evaluation of neurofilaments in early symptom onset amyotrophic lateral sclerosis

E Feneberg, P Oeckl, P Steinacker, F Verde, C Barro… - Neurology, 2018 - AAN Enterprises
Objective To examine neurofilament (Nf) concentrations according to symptom onset and
clinical diagnostic certainty categories of amyotrophic lateral sclerosis (ALS). Methods We …

[HTML][HTML] Deep learning predictions of survival based on MRI in amyotrophic lateral sclerosis

HK van der Burgh, R Schmidt, HJ Westeneng… - NeuroImage: Clinical, 2017 - Elsevier
Amyotrophic lateral sclerosis (ALS) is a progressive neuromuscular disease, with large
variation in survival between patients. Currently, it remains rather difficult to predict survival …

Hypothalamic atrophy is related to body mass index and age at onset in amyotrophic lateral sclerosis

M Gorges, P Vercruysse, HP Müller… - Journal of Neurology …, 2017 - jnnp.bmj.com
Objective Our objective was to study the hypothalamic volume in a cohort of patients with
amyotrophic lateral sclerosis (ALS) including symptomatic and presymptomatic ALS …

[HTML][HTML] Machine learning in amyotrophic lateral sclerosis: achievements, pitfalls, and future directions

V Grollemund, PF Pradat, G Querin, F Delbot… - Frontiers in …, 2019 - frontiersin.org
Background: Amyotrophic Lateral Sclerosis (ALS) is a relentlessly progressive
neurodegenerative condition with limited therapeutic options at present. Survival from …

Adaptive functional reorganization in amyotrophic lateral sclerosis: coexisting degenerative and compensatory changes

M Abidi, G de Marco, A Couillandre… - European Journal of …, 2020 - Wiley Online Library
Background and purpose Considerable functional reorganization takes place in
amyotrophic lateral sclerosis (ALS) in face of relentless structural degeneration. This study …

[HTML][HTML] Pathological neural networks and artificial neural networks in ALS: diagnostic classification based on pathognomonic neuroimaging features

P Bede, A Murad, O Hardiman - Journal of neurology, 2021 - Springer
The description of group-level, genotype-and phenotype-associated imaging traits is
academically important, but the practical demands of clinical neurology centre on the …

Advances in molecular pathology, diagnosis, and treatment of amyotrophic lateral sclerosis

H Ilieva, M Vullaganti, J Kwan - bmj, 2023 - bmj.com
Although the past two decades have produced exciting discoveries in the genetics and
pathology of amyotrophic lateral sclerosis (ALS), progress in developing an effective therapy …

A prospective harmonized multicenter DTI study of cerebral white matter degeneration in ALS

S Kalra, HP Müller, A Ishaque, L Zinman, L Korngut… - Neurology, 2020 - AAN Enterprises
Objective To evaluate progressive white matter (WM) degeneration in amyotrophic lateral
sclerosis (ALS). Methods Sixty-six patients with ALS and 43 healthy controls were enrolled …